iBio, Inc. (IBIO)
1.46
+0.04
(+2.82%)
USD |
NASDAQ |
Aug 25, 12:51
iBio Price to Book Value : 0.6504 for Aug. 25, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 0.6326 |
| August 21, 2026 | 0.6371 |
| August 20, 2026 | 0.6549 |
| August 19, 2026 | 0.6638 |
| August 18, 2026 | 0.646 |
| August 17, 2026 | 0.646 |
| August 14, 2026 | 0.6371 |
| August 13, 2026 | 0.6237 |
| August 12, 2026 | 0.6549 |
| August 11, 2026 | 0.6549 |
| August 10, 2026 | 0.6237 |
| August 07, 2026 | 0.6282 |
| August 06, 2026 | 0.6193 |
| August 05, 2026 | 0.6237 |
| August 04, 2026 | 0.6504 |
| August 03, 2026 | 0.6326 |
| July 31, 2026 | 0.6237 |
| July 30, 2026 | 0.6193 |
| July 29, 2026 | 0.6059 |
| July 28, 2026 | 0.6193 |
| July 27, 2026 | 0.646 |
| July 24, 2026 | 0.6371 |
| July 23, 2026 | 0.6237 |
| July 22, 2026 | 0.6148 |
| July 21, 2026 | 0.6282 |
| Date | Value |
|---|---|
| July 20, 2026 | 0.6103 |
| July 17, 2026 | 0.6148 |
| July 16, 2026 | 0.6014 |
| July 15, 2026 | 0.6371 |
| July 14, 2026 | 0.6415 |
| July 13, 2026 | 0.646 |
| July 10, 2026 | 0.6727 |
| July 09, 2026 | 0.6727 |
| July 08, 2026 | 0.6772 |
| July 07, 2026 | 0.7084 |
| July 06, 2026 | 0.7217 |
| July 02, 2026 | 0.7485 |
| July 01, 2026 | 0.7796 |
| June 30, 2026 | 0.7796 |
| June 29, 2026 | 0.7707 |
| June 26, 2026 | 0.744 |
| June 25, 2026 | 0.7084 |
| June 24, 2026 | 0.7217 |
| June 23, 2026 | 0.7351 |
| June 22, 2026 | 0.7752 |
| June 18, 2026 | 0.7529 |
| June 17, 2026 | 0.7128 |
| June 16, 2026 | 0.6905 |
| June 15, 2026 | 0.7351 |
| June 12, 2026 | 0.7529 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Capricor Therapeutics, Inc. | 1.862 |
| Ocugen, Inc. | -- |
| CytomX Therapeutics, Inc. | 2.438 |
| ACADIA Pharmaceuticals, Inc. | 4.029 |
| Alnylam Pharmaceuticals, Inc. | 23.74 |
Price to Book Value Related Metrics
| PS Ratio | 350.57 |
| Price | 1.46 |
| Earnings Yield | -39.57% |
| Market Cap | 50.43M |